Brief: Accelerate Diagnostics Receives Notice From Nasdaq That It Had Regained Compliance With Minimum Bid Price Requirement
05/06/2024 22:23
June 5 (Reuters) - Accelerate Diagnostics Inc AXDX.O :
* ACCELERATE DIAGNOSTICS - RECEIVED WRITTEN NOTICE FROM
NASDAQ
NOTIFYING CO THAT IT HAD REGAINED COMPLIANCE WITH MINIMUM BID
PRICE REQUIREMENT
Source text for Eikon: ID:n0001104659-24-068734
Further company coverage: AXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Accelerate Diagnostics
See all newsBrief: Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets
Brief: Accelerate Diagnostics files for Chapter 11 bankruptcy
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview
Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview